Literature DB >> 1834862

Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism.

W C Phelps1, S Bagchi, J A Barnes, P Raychaudhuri, V Kraus, K Münger, P M Howley, J R Nevins.   

Abstract

The human papillomavirus E7 gene product is an oncoprotein with properties similar to those of the adenovirus E1A proteins. The human papillomavirus E7 proteins possess substantial amino acid sequence similarity to portions of conserved regions 1 and 2 of E1A, and the human papillomavirus type 16 E7 protein trans-activates the adenovirus E2 early promoter. Analysis of point mutations in the E2 promoter indicated that the E2F recognition sites were critical to E7 stimulation. In contrast to the activation of the E2 promoter, E7 could not trans-activate various other E1A-inducible promoters. Although the promoter specificity for E7 differs from that of 13S E1A trans activation, it is very similar to activation by the E1A 12S product. Moreover, analysis of the E7 protein has suggested that amino acid sequences critical for trans activation include those shared with E1A within conserved region 2. Biochemical studies demonstrate that the E7 protein, like the 12S E1A product, can alter the interaction of cellular factors with the E2F transcription factor. We therefore conclude that E7 trans activation is functionally related to that mediated by the 12S E1A product.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834862      PMCID: PMC250797     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  The cellular transcription factor E2f requires viral E1A and E4 gene products for increased DNA-binding activity and functions to stimulate adenovirus E2A gene expression.

Authors:  L E Babiss
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

2.  The adenovirus E4 gene, in addition to the E1A gene, is important for trans-activation of E2 transcription and for E2F activation.

Authors:  R Reichel; S D Neill; I Kovesdi; M C Simon; P Raychaudhuri; J R Nevins
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Functional and sequence similarities between HPV16 E7 and adenovirus E1A.

Authors:  W C Phelps; C L Yee; K Münger; P M Howley
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

4.  An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity.

Authors:  S Hardy; D A Engel; T Shenk
Journal:  Genes Dev       Date:  1989-07       Impact factor: 11.361

Review 5.  Mechanisms of viral-mediated trans-activation of transcription.

Authors:  J R Nevins
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

6.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Identification of a transforming gene of human papillomavirus type 16.

Authors:  A Tanaka; T Noda; H Yajima; M Hatanaka; Y Ito
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

9.  A point mutational analysis of human papillomavirus type 16 E7 protein.

Authors:  C Edmonds; K H Vousden
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

10.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

Authors:  P Hawley-Nelson; K H Vousden; N L Hubbert; D R Lowy; J T Schiller
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  38 in total

1.  Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130.

Authors:  K Smith-McCune; D Kalman; C Robbins; S Shivakumar; L Yuschenkoff; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.

Authors:  G A Gulliver; R L Herber; A Liem; P F Lambert
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Identification of a 60-kilodalton Rb-binding protein, RBP60, that allows the Rb-E2F complex to bind DNA.

Authors:  S K Ray; M Arroyo; S Bagchi; P Raychaudhuri
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

4.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein.

Authors:  W C Phelps; K Münger; C L Yee; J A Barnes; P M Howley
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Expression of an E1A/E7 chimeric protein sensitizes tumor cells to killing by activated macrophages but not NK cells.

Authors:  Tanya A Miura; Han Li; Kristin Morris; Sharon Ryan; Kristine Hembre; James L Cook; John M Routes
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.

Authors:  Benyue Zhang; Wei Chen; Ann Roman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-28       Impact factor: 11.205

7.  Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53.

Authors:  Deborah Stewart; Anirban Ghosh; Greg Matlashewski
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.

Authors:  Scott Balsitis; Fred Dick; Denis Lee; Linda Farrell; R Katherine Hyde; Anne E Griep; Nicholas Dyson; Paul F Lambert
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression.

Authors:  S W Hiebert
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.